Original Research
Accepted on 12 Jun 2026
Exploratory genomic stratification of benefit from first-line immunotherapy-based combination in advanced biliary tract cancer: A biomarker analysis of a randomized phase 2 trial
in Cancer Immunity and Immunotherapy